IL1B and COVID-19: The immunopathogenesis of COVID-19 is complex, where it has been described that the inflammatory response plays an important role in developing severe forms of the disease and fatal outcomes [36], reporting higher levels of inflammatory mediators such as IL-1β, IL-6, and TNF-α in patients requiring ICU admission compared to patients with mild clinical manifestations [10].